ScholarIQanswers from OpenAlex
Mosaiques Diagnostics and Therapeutics (Germany)
InstitutionResearch output, impact & collaborations
Mosaiques Diagnostics and Therapeutics (Germany) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQrecord summary
Mosaiques Diagnostics and Therapeutics (Germany) is a research organisation in Hanover, DE. OpenAlex records 754 works and 74,954 citations for it. 78 researchers list it as their most recent affiliation.
How many works does Mosaiques Diagnostics and Therapeutics (Germany) have?
ScholarIQindexed works
Mosaiques Diagnostics and Therapeutics (Germany) has 754 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mosaiques Diagnostics and Therapeutics (Germany) have?
ScholarIQcitation count
Mosaiques Diagnostics and Therapeutics (Germany) has 74,954 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQresearcher count
Mosaiques Diagnostics and Therapeutics (Germany) has 78 researchers in the ScholarIQ index.
What is the average h-index at Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQavg h-index
Mosaiques Diagnostics and Therapeutics (Germany) has an average h-index of 99 in OpenAlex.
What is the ROR of Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQror
The ROR for Mosaiques Diagnostics and Therapeutics (Germany) is on the source record.
What is the OpenAlex record for Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQopenalex
The OpenAlex for Mosaiques Diagnostics and Therapeutics (Germany) is on the source record.
Who are the most-cited researchers behind Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQtop researchers by citations
What are the most-cited papers on Mosaiques Diagnostics and Therapeutics (Germany)?
ScholarIQmost cited works
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good, Petra Zürbig, Àngel Argilés, H Bauer, Georg Behrens, Joshua J. Coon, Mohammed Dakna, Stéphane Decramer, Christian Delles, Anna F. Dominiczak, J. H. H. Ehrich, Frank Eitner, Danilo Fliser, Moritz Frommberger, Arnold Ganser, Mark Girolami, Igor Golovko, Wilfried Gwinner, Marion Haubitz, Stefan Herget‐Rosenthal, Joachim Jankowski, Holger Jahn, George Jerums, Bruce A. Julian, Markus Kellmann, Volker Kliem, Walter Kölch, Andrzej S. Królewski, Mario Luppi, Ziad A. Massy, Michael Melter, Christian Neusüß, Jan Novák, Karlheinz Peter, Kasper Rossing, Harald Rupprecht, Joost P. Schanstra, Eric Schiffer, Jens‐Uwe Stolzenburg, Lise Tarnow, Dan Theodorescu, Visith Thongboonkerd, Raymond Vanholder, Eva M. Weissinger, Harald Mischak, Philippe Schmitt‐Kopplin
Clinical proteomics: A need to define the field and to begin to set adequate standards
Harald Mischak, Rolf Apweiler, Rosamonde E. Banks, Mark R. Conaway, Joshua J. Coon, Anna F. Dominiczak, J. H. H. Ehrich, Danilo Fliser, Mark Girolami, Henning Hermjakob, Denis F. Hochstrasser, Joachim Jankowski, Bruce A. Julian, Walter Kölch, Ziad A. Massy, Neusuess Christian, Jan Novák, Karlheinz Peter, Kasper Rossing, Joost P. Schanstra, O. John Semmes, Dan Theodorescu, Visith Thongboonkerd, Eva M. Weissinger, Jennifer E. Van Eyk, Tadashi Yamamoto
Urinary Proteomics in Diabetes and CKD
Kasper Rossing, Harald Mischak, Mohammed Dakna, Petra Zürbig, Jan Novák, Bruce A. Julian, David M. Good, Joshua J. Coon, Lise Tarnow, Peter Rossing
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
Nete Tofte, Morten Lindhardt, Katarina Adamova, Stephan J. L. Bakker, Joachim Beige, Joline W. J. Beulens, Andreas L. Birkenfeld, Gemma Currie, Christian Delles, Ingo Dimos, Lidmila Francová, Marie Frimodt‐Møller, Peter Girman, Rüdiger Göke, Tereza Havrdova, Hiddo J.L. Heerspink, Adriaan Kooy, Gozewijn D. Laverman, Harald Mischak, Gerjan Navis, Giel Nijpels, Marina Noutsou, Alberto Ortíz, Aneliya Parvanova, Frederik Persson, John R. Petrie, Piero Ruggenenti, Femke Rutters, Ivan Rychlík, Justyna Siwy, Goce Spasovski, Marijn M. Speeckaert, Matias Trillini, Petra Zürbig, Heiko von der Leyen, Peter Rossing, Silke Zimmermann, Brit Rädisch, Anika Hävemeier, Annette Busmann, Ulrike Wittkop, Barbara Neuhaus, Regina Ax-Smolarski, Veit Zieglschmid, Eva Bollweber, Heidrun Wölk, Viktor Rotbain Curovic, Ninna Hahn Tougaard, Mie K. Eickhoff, Sascha Pilemann-Lyberg, Signe Abitz Winther, Signe Rosenlund, Tine W. Hansen, Bernt Johan von Scholten, Christian Stevns Hansen, Emilie H. Zobel, Jens Christian Laursen, Simone Theilade, Lone Jelstrup, Tina R. Juhl, Dorthe Riis, Jessie A. Hermann, Anne G. Lundgaard, Maja L.D. Halkjær, Lene Aabo, Therese Frost Lerche, Maria Lajer, Rikke J. Stefansen, Maria Campbell, Annika Durban, Julia Raad, Michael J. Prigge, Marco Schiemann, Robbie Wilson, Sharon Kean, Elizabeth Douglas, Pamela Surtees, Christina M. Gant, Stanley M.H. Yeung, Ilse J. M. Hagedoorn, Joanne Flynn, Joe Galloway, Katriona Brooksbank, Carolina Aparicio, Ilian Iliev, Francesco Nones, Francesca Lo Bue, Daniela Melacini, Daniela Cugini, Silvia Prandini, Verusca Lecchi, Svitlana Yakymchuk, Giulia Gherardi, Alessandro Villa, Davide Villa, Flavio Gaspari, Antonio Cannatà, Silvia Ferrari, Nadia Stucchi, Šárka Albrechtová
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Justyna Siwy, Eric Schiffer, Korbinian Brand, G. Schumann, Kasper Rossing, Christian Delles, Harald Mischak, Jochen Metzger
How much of the research on Mosaiques Diagnostics and Therapeutics (Germany) is open access?
ScholarIQopen access share
86%OPEN ACCESS